title: [Usefulness of olanzapine in the levodopa-induced psychosis in patients with Parkinson's disease].
abstract: BACKGROUND
  To evaluate the antipsychotic efficacy of olanzapine (OLZ) in patients with Parkinson's disease (PD) and drug-induced psychosis (DIP) and its repercussion on the motor function.
  
  
  METHODS
  Ten patients (5 women and 5 men) diagnosed of PD and DIP, aged 67 years (range: 50-81), with PD duration of 11.1 years (range: 6-23), treated chronically with levodopa per day, received a dose of 2.5 or 5.0 mg OLZ daily. Data concerning improvement of psychosis and worsening of motor function was based on Positive And Negative Symptoms Scale (PANSS) and Unified Parkinsons Disease Rating Scale (UPDRS) motor.
  
  
  RESULTS
  Psychotic symptoms were improved in all patients. In most of them the improvement was almost total. Seven patients increased levodopa dose on OLZ, but significant worsening of motor function was reported just in one patient. None of the patients had agranulocytosis in the blood monitoring. Two patients presented weight gain. Seven patients improved their cognitive status.
  
  
  CONCLUSIONS
  We conclude that OLZ at the doses studied may have efficacy for DIP which appears in PD and does not induce worsening of motor function in most of the patients.
authors.affiliation: Servicios de Neurología, Hospital Universitario Virgen Macarena, Sevilla, Spain. jchaconp@supercable.es
authors.forename: J R
authors.initials: JR
authors.lastname: Chacón
authors.forename: E
authors.initials: E
authors.lastname: Durán
authors.forename: J A
authors.initials: JA
authors.lastname: Durán
authors.forename: M
authors.initials: M
authors.lastname: Alvarez
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D010300:Parkinson Disease / Q000188:drug therapy*; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011446:Prospective Studies; D011605:Psychoses, Substance-Induced / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D007980:Levodopa; D000077152:Olanzapine